Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children

Neil A. Goldenberg; Timothy J. Bernard; Jasper Hillhouse; Jennifer Armstrong-Wells; Jeffrey Galinkin; Rhonda Knapp-Clevenger; Linda Jacobson; Santica M. Marcovina; Marilyn J. Manco-Johnson

doi:10.3324/haematol.2012.073833

Haematologica (May 2013)

Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children

Neil A. Goldenberg,
Timothy J. Bernard,
Jasper Hillhouse,
Jennifer Armstrong-Wells,
Jeffrey Galinkin,
Rhonda Knapp-Clevenger,
Linda Jacobson,
Santica M. Marcovina,
Marilyn J. Manco-Johnson

Affiliations

Neil A. Goldenberg: All Children’s Research Institute, All Children’s Hospital–Johns Hopkins Medicine, St. Petersburg, FL;Departments of Pediatrics and Medicine, Divisions of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
Timothy J. Bernard: Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO;The Pediatric Stroke Program and Department of Pediatrics, Sections of Child Neurology, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Jasper Hillhouse: Graduate Medical Education Program, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Jennifer Armstrong-Wells: Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO;The Pediatric Stroke Program and Department of Pediatrics, Sections of Child Neurology, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Jeffrey Galinkin: Department of Anesthesia, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Rhonda Knapp-Clevenger: Colorado Clinical Translational Science Institute, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Linda Jacobson: Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
Santica M. Marcovina: Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington, Seattle, WA
Marilyn J. Manco-Johnson: Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO;The Pediatric Stroke Program and Department of Pediatrics, Section of Hematology/Oncology/BMT University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO, USA

DOI: https://doi.org/10.3324/haematol.2012.073833
Journal volume & issue: Vol. 98, no. 5

Abstract

Read online

Lipoprotein (a) is a risk factor for adult cardiovascular events, in which the apolipoprotein (a) component is thought to promote atherogenesis and impair fibrinolysis. We investigated whether elevated plasma lipoprotein (a) concentration and small predominant apolipoprotein (a) isoform size (number of kringle-4 domains) are risk factors for childhood arterial ischemic stroke and correlate with plasma fibrinolytic function. Patients who had had an arterial ischemic stroke in childhood (29 days - 90th percentile of race-specific reference values and apolipoprotein (a)

Published in Haematologica

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org

About the journal